Kaur Navneet, Lu Xinping, Gershengorn Marvin C, Jain Rahul
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar--160 062, Punjab, India.
J Med Chem. 2005 Sep 22;48(19):6162-5. doi: 10.1021/jm0505462.
Thyrotropin-releasing hormone (TRH) analogues in which the C-2 position of the imidazole ring of the centrally placed histidine residue is substituted with various alkyl groups were synthesized and studied as agonists for TRH receptor subtype 1 (TRH-R1) and subtype 2 (TRH-R2). Several analogues were found to be selective agonists for TRH-R2 exhibiting no activation of TRH-R1. For example, analogue 4 (R= c-C3H5) was found to activate TRH-R2 with a potency (EC50) of 0.41 microM but did not activate TRH-R1 (potency > 100 microM). This study describes the first discovery of TRH-R2-specific agonists and provides impetus to design predominately CNS-effective TRH peptides.
合成了组氨酸残基位于中心的咪唑环C-2位被各种烷基取代的促甲状腺激素释放激素(TRH)类似物,并将其作为TRH受体1型(TRH-R1)和2型(TRH-R2)的激动剂进行研究。发现几种类似物是TRH-R2的选择性激动剂,对TRH-R1无激活作用。例如,发现类似物4(R = c-C3H5)以0.41 microM的效力(EC50)激活TRH-R2,但不激活TRH-R1(效力> 100 microM)。本研究首次发现了TRH-R2特异性激动剂,并为设计主要对中枢神经系统有效的TRH肽提供了动力。